Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02451657 · ClinicalTrials.gov registry record
Non-drug Study to Evaluate the Suitability of Neurocognitive Tests and Functioning Scales for the Measurement of Cognitive and Functioning Changes in Children With Down Syndrome
A clinical trial, sponsored by Hoffmann-La Roche.
- Completed
- Registry status
- 40
- Enrollment target
NCT02451657 is a clinical trial that has completed, run by Hoffmann-La Roche. The registered enrollment target is 40 participants.
The verdict
NCT02451657 has completed, sponsored by Hoffmann-La Roche.
- COMPLETED
- Registry status
- 40 participants
- Enrollment target
Study Summary
The aim of this study is to assess the suitability of selected scales (floor/ceiling effects, variability, test-retest reliability) to measure cognitive function in children with Down syndrome over 6 months, and to evaluate the influence of covariates such as age, gender or language on these neurocognitive scales.
Interventions
- OTHER No Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2015-06-02 |
| Est. Completion | 2016-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02451657
The ClinicalTrials.gov registry entry for NCT02451657 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hoffmann-La Roche, which has 909 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which No Intervention is the first listed.
NCT02451657 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02451657 about?
NCT02451657 is a clinical study titled "Non-drug Study to Evaluate the Suitability of Neurocognitive Tests and Functioning Scales for the Measurement of Cognitive and Functioning Changes in Children With Down Syndrome". The aim of this study is to assess the suitability of selected scales (floor/ceiling effects, variability, test-retest reliability) to measure cognitive function in children with Down syndrome over 6 months, and to evaluate the influence of covariates such as age, gender or language on these neuroco...
What is the current status of trial NCT02451657?
This trial is currently completed. The enrollment target is 40 participants. The study started on 2015-06-02. Estimated completion is 2016-06-30.
What interventions are being tested in trial NCT02451657?
The interventions under investigation include: No Intervention (OTHER).
Who is sponsoring clinical trial NCT02451657?
This trial is sponsored by Hoffmann-La Roche, which has 909 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.